Product FAQ

It quantitatively measures starch in foods, feeds, plants and grains. Enzymes convert starch step by step into measurable glucose, followed by a glucose oxidase/peroxidase color reaction. The method is designed for simple operation, rapid testing and stable results.

An α-amylase first hydrolyzes starch to smaller sugars. Glucoamylase then generates glucose. A glucose oxidase/peroxidase system produces a color signal, and absorbance is used to calculate starch content.

Enzymatic testing uses relatively mild conditions, has good selectivity and a comparatively simple workflow. The coordinated enzymes reduce the impact of complex sample preparation across food, feed and plant matrices.

The multi-enzyme system includes thermostable α-amylase, glucoamylase, glucose oxidase/peroxidase color reagents, associated reaction reagents and standards. Enzyme sources, amounts and conditions are optimized as an integrated assay.

Starch is structurally complex. α-Amylase breaks large molecules into dextrins and oligosaccharides; glucoamylase further converts these products into glucose for the final colorimetric reaction.

It hydrolyzes internal α-1,4-glycosidic bonds, turning starch into dextrins and shorter sugars ahead of saccharification. The stated α-amylase activity is ≥4,000 U/mL.

It further hydrolyzes starch products, including dextrins and oligosaccharides, into glucose for the glucose oxidase/peroxidase reaction. Its stated activity is ≥2,000 U/mL.

Glucose oxidase produces hydrogen peroxide from glucose. Peroxidase then drives a reaction with a chromogenic substrate; the change in absorbance reflects glucose generation and indirectly the starch level.

Starch consists of glucose units linked by glycosidic bonds. After sufficient enzymatic hydrolysis, the resulting glucose is measured against a standard curve and converted to starch content with the appropriate calculation.

A single enzyme mainly addresses part of the hydrolysis step. This kit combines starch breakdown, saccharification and colorimetric detection into a complete quantitative workflow.

Activities do not simply add up. Enzyme source and amount, reaction time and conditions, and interactions between enzymes all influence the final signal. Joint optimization improves matching between reaction steps, stability and efficiency.

The integrated enzyme system combines hydrolysis, saccharification and color development. It aims to be simple, fast, accurate, stable and broadly applicable to food, feed and plant samples.

The kit uses a high-activity thermostable α-amylase with a stated activity of ≥4,000 U/mL. Its activity supports rapid hydrolysis, while thermostability helps it tolerate assay conditions.

The stated activity is ≥2,000 U/mL. Together with α-amylase, it supplies glucose from hydrolysis products for the colorimetric step.

Prepare D-glucose standards at different concentrations, plot absorbance against glucose concentration and fit a line. Convert the sample absorbance to glucose concentration, then account for preparation and conversion factors to obtain starch content.

The current product material shows a standard curve measured at OD510. In practice, follow the wavelength and color-development conditions in the supplied instructions.

The validated D-glucose standard-curve range shown in the current material is 0–1.2 mg/mL. Dilute samples as needed so results fall within the valid range.

Sample color, reducing substances and other matrix components can affect absorbance. Sample and reagent blanks, together with standards, help remove background signal and improve quantitation.

It depends on the matrix. Homogenize complex food, feed or plant samples and choose appropriate extraction, dissolution or dilution. Pretreatment improves starch release while reducing interference with enzyme and color reactions.

Dilution changes both starch concentration and matrix interferents. Too little dilution can exceed the standard curve or cause inhibition; too much can weaken the signal. Choose a valid range and compare parallel dilutions.

The kit is intended for starch in foods, feeds, plants and grains. Optimize pretreatment and dilution for composition, starch level and matrix complexity.

Integrating hydrolysis, saccharification and color development can reduce handling between steps. Follow the reaction times in the product instructions for the actual assay.

The four-enzyme system was jointly optimized for stability and repeatability. The current validation material reports approximately 97% repeatability.

Sealed packaging and optimization of individual enzyme components support storage stability. Current validation indicates more than six months, but use the expiry date and conditions on the batch label and instructions.

Keep sealed and protected from light at 2–8°C. Avoid repeated freezing and thawing and prolonged heat exposure. Follow the product label and instructions for the delivered batch.

The kit integrates thermostable α-amylase, glucoamylase and glucose oxidase/peroxidase color development, with enzyme amounts and reaction conditions jointly optimized. This supports a faster, more standardized and reproducible quantitative method than workflows requiring many separate manual steps.

The assay is a coupled multistep system. Accuracy also depends on enzyme ratios, matched reaction rates, substrate conversion and the color system. Increasing one enzyme alone may not help; the whole reaction needs optimization.

Different enzymes handle starch breakdown, saccharification and signal generation. Matching their amounts and conditions allows each product to feed the next step, reducing intermediate buildup and incomplete-reaction error.

Standards establish the relationship between concentration and signal. A standard curve converts sample absorbance to concentration, after which sample preparation and dilution factors yield final starch content.

PaAst is an arylsulfatase that hydrolyzes aryl sulfate ester bonds. It can be used in assays and bioconversions involving sulfate-ester substrates. This recombinant product is expressed in Pichia pastoris and purified as a high-purity enzyme.

It hydrolyzes aryl sulfate esters, cleaving the sulfate-ester bond and releasing the corresponding products. This supports enzymatic analysis, detection and bioconversion.

They occur in microorganisms, plants and animals. Traditional products may be extracted from natural material, whereas PaAst is produced by recombinant Pichia fermentation and purification.

Fermentation followed by protein purification supports a stable recombinant production system and reduces dependence on naturally sourced material.

Recombinant PaAst is produced through genetic engineering and purified after expression; natural enzymes are extracted from tissues or microorganisms. Recombinant production makes the source clearer and can improve standardization and batch control.

The product material states purity of ≥99% after protein purification. High purity helps reduce interference from unrelated proteins in assays and downstream applications.

The listed advantages are stability, purity, batch consistency, a recombinant alternative to natural sources and broad compatibility. Standardized expression and purification support assay and industrial uses.

It does not require direct extraction from natural tissue. A controlled expression and purification process can provide an enzyme of defined source and high purity as a recombinant alternative.

Depending on the substrate and method, it may be developed for aryl-sulfate assays in clinical testing, forensic toxicology, agricultural assessment and environmental testing.

After recombinant expression, standardized protein purification removes host proteins and other impurities. Protein analysis shown on the product page indicates high purity.

It reduces effects of host proteins and impurities on enzyme activity, substrate reactions and analysis, particularly where low assay background and batch consistency matter.

Recombinant expression and standardized purification can reduce variation associated with natural raw materials. Consult the actual batch test report for batch-specific figures.

The product recommends storage at −20°C and avoiding repeated freeze–thaw cycles. For short-term use, follow the instructions for low-temperature storage.

Low temperature reduces protein degradation and activity loss. Follow specified long-term storage conditions and minimize freeze–thaw cycles.

Freezing and thawing may cause changes in local concentration, aggregation or protein conformation, affecting activity and stability. Aliquot according to expected use.

Yes, if the application requires it. Design a multi-enzyme system around substrate specificity, preferred conditions and stability; optimize blending ratios for the target workflow.

Its high purity and clearly defined recombinant source make it a potential tool enzyme for substrate hydrolysis, signal generation and assay-method development involving aryl sulfates.

Pichia expression and purification provide a defined source, high purity, potential batch consistency and a more standardized process compared with extraction from natural material.

Possible development areas include clinical diagnostics, forensic toxicology, agricultural assessment and environmental work: for example related disease screening, hydrolysis of urine conjugates, doping analysis, soil sulfur-cycle studies, agar desulfation and pollutant degradation.

GUS hydrolyzes β-glucuronide bonds in a range of glucuronide conjugates. This recombinant product is expressed in Pichia pastoris and purified for analytical and bioanalytical use.

It cleaves β-glucuronide bonds, releasing free compounds from glucuronide conjugates. This can prepare conjugated analytes for subsequent detection.

GUS occurs in microorganisms, animals and other systems. This product uses recombinant Pichia expression followed by fermentation and purification rather than direct extraction.

Recombinant expression and purification support a standardized process, a defined source and consistent production of high-purity enzyme.

Recombinant GUS is produced through engineered expression; naturally sourced GUS is isolated from tissue or microorganisms. Recombinant production can reduce raw-material variability and aid purity and batch control.

The product material states purity of ≥99% after purification. This helps reduce interference from unrelated proteins and supports assay stability.

The product highlights activity, stability, purity and batch consistency. Pichia expression and purification are intended to support analytical and related biological applications.

It hydrolyzes β-glucuronide bonds in suitable substrates. The resulting reaction can be linked to qualitative or quantitative signals in an assay.

It turns conjugated analytes into free forms by enzymatic hydrolysis, aiding later analysis. Select substrate and detection method for the target compound.

Yes, depending on the assay. GUS acts on glucuronides and arylsulfatase on sulfate esters; a combined system may process both conjugate types if conditions are optimized.

Complex biological samples can contain both glucuronide and sulfate conjugates. The two enzymes address different linkages and can broaden hydrolysis coverage in sample preparation.

High purity limits interference from host proteins and other impurities, helping analytical assays, enzymology studies and prodrug-activation research produce clearer, more stable results.

Standardized Pichia expression and purification can reduce variation from natural source materials. The product positioning emphasizes stability and batch control for standardized assays.

It may be coupled to colorimetric or other signal systems. Standardizing enzyme dose, substrate concentration and reaction conditions can improve consistency when processing many samples.

Use a suitable β-glucuronide substrate and monitor the detectable hydrolysis product. Define activity conditions for the chosen substrate, buffer, temperature and detection method.

Optimum pH, temperature and substrate conditions vary by enzyme source. Follow this product's instructions for recommended conditions and stable results.

Low-temperature storage limits degradation and activity loss. Shelf life is determined by the label and stability validation; avoid prolonged heat and repeated freeze–thaw cycles.

Store at −20°C and avoid repeated freeze–thaw cycles; short-term storage at 4°C may be used as instructed. Follow the actual label and instructions for shelf life.

Pichia expression and purification offer a defined source, high purity, stability and batch consistency as an alternative to naturally extracted enzyme.

Potential areas include forensic toxicology, clinical diagnostics, environmental and microbial testing, and prodrug-activation research, including urine-conjugate hydrolysis, doping analysis and related detection studies.

The source material describes a rationally designed, Pichia-expressed enzyme with high purity, stability and activity, no animal-tissue extraction, and activity ≥3,000 U/mg. It is presented as an alternative to traditional extraction.

Pig-derived pepsin is extracted from gastric mucosa and may vary with source material. Recombinant pepsin is made in a microbial expression system without animal-derived raw material, supporting more controlled production and quality.

It hydrolyzes proteins and can be studied in food and feed processing, health products, collagen extraction, leather processing, and research assays. The source describes a rationally designed variant with activity around 3,000 U/mg.

The approved FAQ reports stability for two years at −20 ± 5°C and after three freeze–thaw cycles. Confirm the actual shelf life and storage conditions on the delivered batch label.

Pepsin is an aspartic protease. Catalytic Asp32 and Asp215 cleave peptide bonds through acid–base catalysis, with a preference for sites near certain aromatic and hydrophobic amino acids.

The source FAQ reports highest activity at pH 1–3, around pH 2, and irreversible inactivation above pH 6. Choose temperature and conditions according to the actual product instructions and application.

The source material reports similar kinetic behavior, pH/temperature response and structure, with an activity optimum near pH 2. The recombinant process is intended to improve specific activity and batch consistency.

Pepsinogen activates under acidic conditions as its N-terminal prosegment is removed. The source describes activation below pH 5; follow the delivered product's procedure before use.

Pichia pastoris is used for recombinant expression, followed by fermentation and purification. The system supports controlled production of a high-purity enzyme without direct animal-tissue extraction.

It is generally expressed as pepsinogen to protect the host from proteolysis, then activated under acidic conditions into mature pepsin.

The source FAQ states that microbial expression avoids animal-derived ingredients. Suitability for halal, kosher or vegan claims must still be confirmed against the full manufacturing process and any required certification.

The source FAQ contrasts traditional extraction with recombinant production. Double Win's enzyme is expressed recombinantly, fermented and purified; the cited research data include expression of 100 mg/L and activity of 3,948 U/mL.

Natural-source extraction may be affected by raw-material supply and batch variation. Recombinant production is intended to improve expression, activity, reliability and process suitability.

It hydrolyzes fructan glycosidic bonds to produce fructose-containing fragments or fructooligosaccharides. Endo- and exo-acting forms differ in how they cut the substrate; product-specific substrate specificity should be checked in its technical data.

The source FAQ reports 3,948 U/mL for the recombinant preparation and 2,132 U/mL for an extracted enzyme at the same protein concentration, an increase of about 85% under those comparison conditions.

It may help produce fructooligosaccharides for food formulations. Assess substrate, conversion products and applicable food regulations for the intended use.

The recombinant process is intended to support batch consistency. The product recommends storage at −20°C without repeated freeze–thaw cycles; short-term storage at 4°C may be used.

The source lists prebiotic production for foods, feed applications, digestive-enzyme research, biofuels and cleaning-related uses.

The source describes research into reducing fructans through enzymatic hydrolysis. Any digestive or health-related product claim requires product-specific evidence and regulatory review.

Fructan hydrolysis can supply fermentable sugars from inulin-rich feedstocks such as Jerusalem artichoke. The source also notes potential in biofuel and cleaning applications.

Jerusalem artichoke contains inulin. Fructanase can convert it into fructose or fructooligosaccharides that may feed later fermentation to fuels or other chemicals.

Optimize conditions for the substrate and process. Contact the technical team for a process-specific enzyme-use proposal.

Consider substrate concentration, target product, reaction time and process conditions. The source reports activity of 3,948 U/mL; determine actual dosage through bench-scale trials.

Time depends on substrate, enzyme dose, temperature and pH. Optimize the actual reaction duration in the target process.

Yes. A blend may be designed around process needs and complementary catalytic steps; optimize enzyme ratios for the target reaction.

The enzyme is expressed in E. coli and purified after fermentation. Standardized production can reduce natural-source variability; use batch quality documents to assess actual consistency.

CrAT catalyzes reversible acetyl transfer between acetyl-CoA and carnitine, producing acetylcarnitine and CoA. It participates in mitochondrial fatty-acid oxidation and energy metabolism and is relevant to related research.

The source FAQ describes extraction from pigeon muscle, with limited supply, stability and batch consistency. Recombinant expression is intended to provide a more controlled source with stated activity ≥50 U/mg.

Double Win's CrAT is expressed in E. coli and purified after fermentation. The source FAQ describes it as a high-purity, high-activity recombinant preparation with activity ≥50 U/mg.

The stated activity is ≥50 U/mg. Higher activity can improve catalytic output at a given enzyme dose, subject to the actual assay and process conditions.

The E. coli-expressed enzyme is purified after fermentation. The product catalogue states purity ≥99%; batch-specific quality-control results should be checked for delivered material.

The listed advantages are activity, a stable production source, purity, repeatability and stability, with reduced dependence on animal-tissue extraction.

CrAT is studied in metabolic pathways associated with diabetes and cancer. The recombinant enzyme can be used as a research reagent for mechanistic studies, screening and target validation; it is not a therapeutic product.

Because CrAT participates in energy-metabolism regulation, it may support research on exercise capacity and fatigue. The product is an enzyme reagent for related research.

The enzyme may be evaluated for L-carnitine assays and inherited-metabolic-disease screening research. Validate sensitivity and stability within the particular assay.

Yes, its reversible reaction with acetyl-CoA and carnitine can be incorporated into an enzymatic assay. The product is a candidate enzyme ingredient for L-carnitine assay development.

The source FAQ discusses research involving abnormal CrAT activity and inherited metabolic disease. Suitability for a screening assay requires method-specific validation and regulatory compliance.

CrAT is involved in mitochondrial fatty-acid oxidation and energy metabolism, making it relevant to mechanistic studies and target screening in diabetes, obesity and related conditions.

It may serve in research screening of compounds targeting related metabolic pathways. Enzyme consistency and assay conditions must be validated for the screening platform.

CrAT is studied in metabolic reprogramming. Recombinant CrAT can be used as an enzyme reagent for cancer-metabolism research, not as a clinical treatment.

The source discusses CrAT's role in energy metabolism and possible research into exercise tolerance and fatigue. Any finished-product health claim requires independent evidence and regulatory review.

The source groups applications into metabolic-disease research, exercise-related research, and L-carnitine or inherited-disease assay development. It also mentions mechanistic studies and compound screening. The product's stated activity is ≥50 U/mg.

The source FAQ describes a selective protease that targets sequences containing umami-associated amino acids such as aspartate and glutamate. It reports a two- to threefold improvement in umami effect in the tested food applications.

The enzyme is used to release saltiness-enhancing peptides through targeted hydrolysis. The aim is to maintain perceived saltiness while reducing sodium chloride in suitable food formulations; actual replacement depends on testing.

A sequence of endo- and exo-protease steps releases endogenous umami peptides from food proteins. In the oyster example cited by the source, the resulting umami value was about twice that of the conventional process while total amino-acid content was broadly unchanged.

The source reports roughly five times more umami-associated amino acids after the selective hydrolysis process and overall umami intensity about 1.6 times that of conventional water extraction.

The source describes a sequential hydrolysis process and reports an umami-intensity increase of about 2.1 times, with some measures more than 60% higher, producing a fuller aftertaste.

Selective hydrolysis releases saltiness-enhancing peptides from shiitake. The source reports 25–50% salt replacement at equivalent perceived saltiness and saltiness intensity about three times the pre-hydrolysis level under its stated tests.

No fixed MSG replacement percentage is stated. The source reports 25–50% salt replacement under equivalent-saltiness conditions and umami improvements for oyster, soybean-meal and Stropharia sources. MSG substitution must be tested for each formulation and flavor target.

Selective proteases are used to release particular functional peptides, such as soy ACE-inhibitory peptides or umami and saltiness peptides. Less selective hydrolysis may give broader fragment distributions and lower yields of the desired peptides.

The source describes AI-assisted enzyme design, selective proteases and sequential endo-/exo-protease hydrolysis. It cites increased umami-associated amino acids in soybean meal and a small-peptide fraction of 91.1% in a corn-protein experiment.

No fixed MSG replacement percentage is stated. The source reports 25–50% salt replacement under equivalent-saltiness conditions and umami improvements for oyster, soybean-meal and Stropharia sources. MSG substitution must be tested for each formulation and flavor target.

The source describes a proprietary enzyme approach for producing soy peptides with ACE-inhibitory activity, with potential application in food and pharmaceutical research.

Targeted hydrolysis releases peptides of interest. The source cites an SHR animal-model observation of systolic pressure decreasing by 16 mmHg and diastolic pressure by 9 mmHg, and related publications. These are research observations, not a clinical efficacy claim.

The source mentions soy beverages and protein tablets among possible formats. Final safety, efficacy and health claims require product-specific evaluation and applicable regulatory approval.

Targeted hydrolysis breaks up the naturally hydrophobic protein structure. The source reports water solubility rising from about 12% to above 80%, α-zein hydrolysis above 90%, and a small-peptide fraction of 91.1% under the tested conditions.

The cited figures are water solubility above 80% (about sevenfold improvement), small active peptides at 91.1%, acid-soluble protein rising from 45% to 78%, and water-soluble protein rising from 12.4% to 84.60%.